Aspira Women's Health Inc.
corporate_fare Company Profile
Aspira Women's Health Inc. (OTC:AWHL) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 8 items for AWHL at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-07-15, rated 7/10. Across its 8 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for AWHL spans 10-K, 8-K/A, 8-K, 424B3.
Recent high-impact activity:
- Aspira Women's Health Lands $1.05M Subordinated Loan, Interest Costs $441K
- Aspira Women's Health Raises $1.49M in Private Placement, Stock Sold Above Market Price
- Aspira Women's Health Reports Q1 Net Income of $676K, EPS Loss Narrows to ($0.05) Despite Revenue Drop
- Aspira Women's Health Faces Going Concern Doubt Amid Nasdaq Delisting and ARPA-H Contract Termination
- Aspira Women's Health Finalizes Laboratory Services Agreement with Mayo Clinic Laboratories
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 7,294 shares in AWHL as of the September 15, 2026 settlement, a 61.4% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On October 2, 2026, 0.6% of AWHL volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.